Antisense Therapy for a Common Corneal Dystrophy Ameliorates TCF4 Repeat Expansion-Mediated Toxicity.

Am J Hum Genet · 2018 · PMC5985359 · PMID 29526280

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Here we demonstrate that the TCF4 CTG18.1 expansion confers a highly significant disease risk in our large cohort of individuals affected by FECD.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.